AlloVir, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
26.25
|
|
Average Rating
|
4.25
|
|
# Strong Buys
|
1
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.53
|
-0.50
|
0.03
|
5.66%
|
|
2022-06-30
|
-0.73
|
-0.69
|
0.04
|
5.48%
|
|
2022-03-31
|
-0.80
|
-0.69
|
0.11
|
13.75%
|
|
2021-12-31
|
-0.81
|
-0.92
|
-0.11
|
-13.58%
|
|
2021-09-30
|
-0.55
|
-0.72
|
-0.17
|
-30.91%
|
|
2021-06-30
|
-0.49
|
-0.60
|
-0.11
|
-22.45%
|
|
2021-03-31
|
-0.40
|
-0.50
|
-0.10
|
-25.00%
|
|
2020-12-31
|
-0.42
|
-0.34
|
0.08
|
19.05%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.88
|
|
2021-12-31
|
-2.74
|
|
2020-12-31
|
-5.17
|